Skip to content
OpenCapital
Get started

ClearPoint Neuro CLPT EBIT

EBIT at other companies

IAR
Integra LifeSciencesIART
$11.47M+174%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-$14.44M+70.5%
Abbott logo
AbbottABT
——
Boston Scientific logo
Boston ScientificBSX
——
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
——
Medtronic logo
MedtronicMDT
——

Other financials

Income statement

See full
Revenue$12.1M+42.9%
Gross profit$7.8M+51.1%
Operating income-$8.5M-37.6%
Net income-$9.6M-58.5%
EPS (diluted)-$0.32-45.5%

Balance sheet

See full
Cash & equivalents$36.5M+195%
Total debt$63.6M+1,750%
Total equity$18.8M-5.7%
Total assets$93.4M+211%

Cash flow

See full
Operating cash flow-$8.0M-29.1%
CapEx$645.0K+252%
Free cash flow-$8.6M-35.5%

Valuation

See full
Market cap$538.61M+69.2%
Enterprise value$565.68M+82.9%
P/S13.3×+3.4×

Profitability

See full
Gross margin62.3%+1.1pp
Operating margin-65.2%-1.9pp
Net margin-71.6%+8.8pp
FCF margin-65.7%+269pp

Returns & leverage

See full
Return on equity-149.7%+4,074pp
Debt / equity3.4×+3.2×
Current ratio5.8×+2.3×

Where this comes from

Calculated from ClearPoint Neuro’s reported figures.

−$8.5Moperating income−$9.5Mincome before tax+$1.4Minterest expense=-$8.48M

The official record: ClearPoint Neuro’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about ClearPoint Neuro's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ClearPoint Neuro's EBIT?
ClearPoint Neuro (CLPT) reported EBIT of -$8.48M in Q1 2026.
How has ClearPoint Neuro's EBIT changed year-over-year?
ClearPoint Neuro's EBIT decreased by 37.6% year-over-year, from -$6.16M to -$8.48M.
What is the long-term trend for ClearPoint Neuro's EBIT?
Over 4 years (2021 to 2025), ClearPoint Neuro's EBIT has grown at a 15.9% compound annual growth rate (CAGR), from -$13.37M to -$24.16M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.